An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes
Clinical trial NCT01022112 · COMPLETED
Trial details
- NCT number
- NCT01022112
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2010-09-01
- Enrollment
- 383
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.